Pharmaceuticals UltraSector ProFund

The Pharmaceuticals UltraSector ProFund seeks daily investment results, before fees and expenses, that are 1.5x the return of the Dow Jones U.S. Select Pharmaceuticals Index (the "Index") for a single day.

Fund Snapshot

Investor Class Service Class
CUSIP 743185423 743185415
Fund Number 047 077
Inception Date 6/28/2000
Fund Group Sector ProFunds - UltraSector

Fund Statistics

Limits On Exchanges None
Minimum Investment
Individual Investor $15,000
Financial Professionals $5,000

NAV as of 6/11/2021

Class NAV % Change $ Change
Investor $29.74 -1.26% -$0.38 NAV History
Service $25.36 -1.25% -$0.32 NAV History
PHPIX Current Quote and Chart

Chart data provided by Thomson Reuters.

Returns (as of 3/31/2021)

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost.

For standardized returns year-to-date, and as of the most recent calendar quarter-end, and annualized month-end, see performance. Returns include the reinvestment of dividends and capital gains.

YTD (as of 6/11/2021) 7.09%
Average Annual One Year 49.38%
Average Annual Three Year 7.05%
Average Annual Five Year 6.32%
Average Annual Ten Year 13.89%
Average Annual Since Inception 2.74%
Cumulative Since Inception 75.23%
Gross Expense Ratio 2.32%
Net Expense Ratio * 1.78%

* Contractual waiver effective from December 1, 2020 through November 30, 2021. Without such a waiver of fees, the total returns may have been lower.

All data, unless otherwise noted, is as of 3/31/2021 and for Investor Class Shares only and is subject to change.


Dow Jones U.S. Select Pharmaceuticals Index*

The Index (Bloomberg Ticker: DJSPHM) measures the performance of the pharmaceuticals sector of the U.S. equity market. Component companies include, among others, manufacturers of prescription or over-the-counter drugs. The Index includes vaccine producers, but excludes vitamin producers. It is not possible to invest directly in an index.

Total Index Companies 45
Price/Earnings Ratio 113.36
Price/Book Ratio 3.62
Dividend Yield 1.84%
Average Index Market Capitalization 30.67 billion

Index as of 3/31/2021

Index Sector Weightings Weight
Pharmaceuticals 96.32%
Biotechnology 3.68%

Index as of 3/31/2021

Top 10 Index Companies Weight
Johnson & Johnson 23.14%
Pfizer Inc. 17.56%
Merck & Co. Inc. 5.65%
Zoetis Inc. 4.67%
Bristol-Myers Squibb Co. 4.64%
Horizon Therapeutics plc 4.62%
Catalent Inc. 4.58%
Viatris Inc. 4.45%
Eli Lilly & Co. 4.07%
Elanco Animal Health Inc. 4.03%

You are leaving the ProFunds website. ProFunds is not responsible for information provided on third-party websites.